Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics ...

New Evrysdi five-year data from the SUNFISH study showed continued stabilisation of motor function in a broad population of ind ...

Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ETCompany ParticipantsBruce Mackle - LifeSci Advisors, ...

An integrated Poster & Exhibition ... Head of Medical & Scientific Affairs, Pulmotree. “Estoril is a great location to celebrate 20 years of RDD Europe conferences. I can’t wait to catch ...

Presentation: First Report of Phase Ib/2a Study Evaluating Safety and Early Efficacy of TN-201, an Adeno-Associated Virus Serotype 9 Gene Replacement Therapy, in Adults with MYBPC3 -Associated ...

On track for multiple clinical updates through mid-2026, including further progress from two ongoing clinical programs and initiation of ...

Seventy-one University of Kentucky students will present their research at the National Conference on Undergraduate Research (NCUR), April 7-9 at Duquesne University in Pittsburgh.

The Christ the King Catholic School sixth graders each took turns explaining their project — titled “Glass Beads for the ...

Q4 2024 Earnings Call Transcript March 13, 2025 aTyr Pharma, Inc. beats earnings expectations. Reported EPS is $-0.18, expectations were $-0.23. Operator: Good afternoon, ladies and gentlemen, and ...

Topline data from Phase 3 EFZO-FIT study of efzofitimod in pulmonary sarcoidosis expected in the third quarter of 2025. Fourth positive DSMB review for efzofitimod in Phase 3 EFZO-FIT study reinforces ...

For decades, military leaders have been discussing climate change as a threat and a threat multiplier that could worsen ...

If you exist on planet Earth, you know that as the guitar loop from Sabrina Carpenter’s “Espresso,” which is an inescapable ...